CanSinoBIO’s overseas business is evolving from a strategic initiative into an increasingly important contributor to the Company’s performance...
Fosun International recorded total revenue of RMB86.96 billion. Overseas revenue reached RMB49.16 billion...
The C22 features a 5 kW/110 kHz generator, with pulsed fluoroscopy of up to 40 mA and 30 frames per second (fps)...
Pertussis is a highly contagious acute respiratory infectious disease caused by Bordetella pertussis...
The on-schedule acceptance underscores the Company's disciplined execution of its clinical and regulatory strategy...
The three-day exhibition in northeast China covers medical imaging, in vitro diagnostics, surgical systems, AI healthcare, telemedicine, robotics and hospital infrastructure....
The 360-patient study showed statistically significant improvement in 90-day functional outcomes, with no investigational drug-related serious adverse events reported....
Harnessing dual-device synergies, multi-energy technologies, and pioneering layered protocols, Sisram cements its strategic leadership across APAC...
Fosun International expects first-half profit to rise by 127% to 172%, supported by its core businesses as Fosun Pharma records new drug and clinical trial application progress....
The upgraded service system is designed around risk prevention and proactive intervention, supporting a shift from traditional reactive healthcare towards preventive and personalised health management...
